Effect of Talactoferrin Alfa on the Immune System in Adults With Non-Small Cell Lung Cancer

BACKGROUND. Talactoferrin alfa (talactoferrin), an agent with immune-stimulating properties, has demonstrated safety and preliminary efficacy in clinical trials. METHODS. Ten patients (five males and five females) with stage IV non-small cell lung cancer (NSCLC) in a single-arm pilot study received...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Madan, Ravi A., Tsang, Kwong-Yok, Bilusic, Marijo, Vergati, Matteo, Poole, Diane J., Jochems, Caroline, Tucker, Jo A., Schlom, Jeffrey, Giaccone, Giuseppe, Gulley, James L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2013
Gaiak:
Clinical Trial Results
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720636/
https://ncbi.nlm.nih.gov/pubmed/23847257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0199
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak